Literature DB >> 22058211

POEMS syndrome with severe neurological damage clinically recovered with lenalidomide.

José F Tomás, Pilar Giraldo, Ramón Lecumberri, Sara Nistal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22058211      PMCID： PMC3269496          DOI： 10.3324/haematol.2011.041897

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

1.  Lenalidomide therapy in a patient with POEMS syndrome.

Authors:  Angela Dispenzieri; Christopher J Klein; Michelle L Mauermann
Journal:  Blood       Date:  2007-08-01       Impact factor: 22.113

2.  Lenalidomide therapy in a rare case of POEMS syndrome with kappa restriction.

Authors:  Saurabh Sethi; Nishant Tageja; Haitham Arabi; Raju Penumetcha
Journal:  South Med J       Date:  2009-10       Impact factor: 0.954

3.  Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome.

Authors:  O Watanabe; I Maruyama; K Arimura; I Kitajima; H Arimura; M Hanatani; K Matsuo; T Arisato; M Osame
Journal:  Muscle Nerve       Date:  1998-11       Impact factor: 3.217

Review 4.  POEMS syndrome.

Authors:  Angela Dispenzieri
Journal:  Blood Rev       Date:  2007-09-11       Impact factor: 8.250

5.  Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature.

Authors:  Angela Dispenzieri; Alvaro Moreno-Aspitia; Guillermo A Suarez; Martha Q Lacy; Gerardo Colon-Otero; Ayalew Tefferi; Mark R Litzow; Vivek Roy; William J Hogan; Robert A Kyle; Morie A Gertz
Journal:  Blood       Date:  2004-07-27       Impact factor: 22.113

6.  Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome.

Authors:  S Kuwabara; S Misawa; K Kanai; S Sawai; T Hattori; M Nishimura; C Nakaseko
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-05-09       Impact factor: 10.154

7.  Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome.

Authors:  R K Gherardi; L Bélec; M Soubrier; D Malapert; M Zuber; J P Viard; L Intrator; J D Degos; F J Authier
Journal:  Blood       Date:  1996-02-15       Impact factor: 22.113
  7 in total
  11 in total

1.  High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.

Authors:  Gordon Cook; Simona Iacobelli; Anja van Biezen; Dimitris Ziagkos; Veronique LeBlond; Julie Abraham; Grant McQuaker; Stefan Schoenland; Alessandro Rambaldi; Kazimierz Halaburda; Maria Rovira; Simona Sica; Jenny Byrne; Ramon Garcia Sanz; Arnon Nagler; Niels W C J van de Donk; Marjatta Sinisalo; Mark Cook; Nicolaus Kröger; Theo De Witte; Curly Morris; Laurant Garderet
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

2.  Durable responses with autologous hematopoietic SCT in patients with POEMS syndrome.

Authors:  K Patel; M Nusrat; N Shah; Q Bashir; S Parmar; J Shah; S Thomas; D Weber; R Z Orlowski; R Champlin; M H Qazilbash
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

3.  Long-Term Therapy with Lenalidomide in a Patient with POEMS Syndrome.

Authors:  Benjamin F Chu; Arwa Shana'ah; Craig C Hofmeister; Don M Benson; Megan Sell; Jill Tucker; Flavia Pichiorri; Yvonne A Efebera
Journal:  Eur J Case Rep Intern Med       Date:  2014

Review 4.  Advances in the Treatment of Paraproteinemic Neuropathy.

Authors:  Eduardo Nobile-Orazio; Mariangela Bianco; Andrea Nozza
Journal:  Curr Treat Options Neurol       Date:  2017-10-16       Impact factor: 3.598

5.  Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases.

Authors:  Xinping Zhou; Juying Wei; Yinjun Lou; Gaixiang Xu; Min Yang; Hui Liu; Liping Mao; Hongyan Tong; Jie Jin
Journal:  Front Med       Date:  2017-04-03       Impact factor: 4.592

6.  Pulmonary morbidity improves after autologous stem cell transplantation in POEMS syndrome.

Authors:  Satish Chandrashekaran; Angela Dispenzieri; Stephen S Cha; Cassie C Kennedy
Journal:  Respir Med       Date:  2014-11-14       Impact factor: 3.415

Review 7.  How I treat POEMS syndrome.

Authors:  Angela Dispenzieri
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

8.  Lenalidomide and Dexamethasone for a Patient of POEMS Syndrome Presenting with Massive Ascites.

Authors:  Shuji Ueda; Sayoko Yonemoto; Kazumasa Oka; Naohiko Fujii; Keiichi Nakata; Hitomi Matsunaga; Seiko Kataoka; Yuki Iwama; Hiroyuki Narahara; Yuichi Yasunaga; Yoshiaki Inui; Sumio Kawata
Journal:  Case Rep Hematol       Date:  2014-02-19

9.  [POEMS syndrome: a diagnosis to not to ignore].

Authors:  Madiha Mahfoudhi; Sami Turki; Adel Kheder
Journal:  Pan Afr Med J       Date:  2015-04-30

10.  A rare cause of pericardial effusion and ascites: POEMS syndrome.

Authors:  Bilal Katipoglu; Zeynep Katipoğlu; Ihsan Ates; Gokhan Yirgin; Burak Furkan Demir; Fatih Acehan
Journal:  Hematol Rep       Date:  2017-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.